Search

In Stock

Buy Zegalogue (dasiglucagon) Online

DISEASE INDICATIONS: Diabetes

MANUFACTURER: Zeeland Pharma

USAGE: Subcutaneous

MEDICINE APPROVED BY:

Food and Drug Administration (FDA)

Zegalogue (dasiglucagon) is a prescription medication used to treat severe hypoglycemia (very low blood sugar) in adults and children with diabetes aged 6 years and older.

From $312.85

Clear
Compare

Zegalogue (dasiglucagon) is a prescription medication used to treat severe hypoglycemia (very low blood sugar) in adults and children with diabetes aged 6 years and older.

How does Zegalogue work?

Zegalogue is a glucagon receptor agonist. Glucagon is a hormone that helps to raise blood sugar levels. Zegalogue works by stimulating glucagon receptors in the liver, which causes the liver to release glucose into the bloodstream.

How is Zegalogue used?

Zegalogue is given as a single injection under the skin. The recommended dose for adults and children aged 6 years and older is 0.6 mg. If there is no response after 15 minutes, an additional 0.6 mg dose may be given.

What are the side effects of Zegalogue?

The most common side effects of Zegalogue are:

  • Nausea
  • Vomiting
  • Headache
  • Diarrhea
  • Injection site pain

Zegalogue can also cause more serious side effects, such as:

  • Allergic reactions
  • Increased heart rate
  • Increased blood pressure
  • Decreased blood sugar levels (too low)

Who should not take Zegalogue?

Zegalogue should not be taken by people who are allergic to dasiglucagon or any of the other ingredients in Zegalogue. It should also not be taken by people with:

  • Pheochromocytoma (a rare tumor of the adrenal gland)
  • Severe insulinoma (a tumor of the pancreas that produces too much insulin)

Important safety information

It is important to tell your doctor about all of the medications you are taking before starting Zegalogue. Zegalogue can interact with other drugs, such as beta-blockers and calcium channel blockers.

Zegalogue should be used with caution in people with heart disease, high blood pressure, and kidney disease.

Zegalogue can cause serious side effects, such as allergic reactions and decreased blood sugar levels. It is important to monitor your blood sugar levels closely while taking Zegalogue.

If you are considering taking Zegalogue, talk to your doctor about the risks and benefits of the medication.

Package

1 prefilled auto-injector of 0.6mg/0.6mL, 1 prefilled syringe of 0.6mg/0.6mL, 2 prefilled auto-injectors of 0.6mg/0.6mL, 2 prefilled syringes of 0.6mg/0.6mL

Reviews

There are no reviews yet.

Write a review

Your email address will not be published. Required fields are marked *

Bestsellers

Buy Waylivra (volanesorsen) Online

$11,550.76
(0 Reviews)
DISEASE INDICATIONS: Familial chylomicronemia syndrome (FCS) MANUFACTURER: Akcea Therapeutics Ireland Limited USAGE: Subcutaneous MEDICINE APPROVED BY: European Medical Agency (EMA) Waylivra (volanesorsen) is a prescription medication used to treat adults with genetically confirmed familial chylomicronemia syndrome (FCS) and at high risk for pancreatitis, in whom response to diet and triglyceride lowering therapy has been inadequate. FCS is a rare genetic disorder that causes the body to produce too much of a type of fat called chylomicrons. Chylomicrons can build up in the blood and cause pancreatitis, a serious inflammation of the pancreas.

Buy Isturisa (osilodrostat) Online

From $1,818.17
(0 Reviews)
DISEASE INDICATIONS: Primary Biliary Cholangitis (PBC) MANUFACTURER: Novartis USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Isturisa (osilodrostat) is a cortisol synthesis inhibitor used to treat Cushing's syndrome, a condition in which the body produces too much of the hormone cortisol. It is approved by the US Food and Drug Administration (FDA) for adults with Cushing's disease, a type of Cushing's syndrome caused by a tumor on the pituitary gland, and for adults with endogenous Cushing's syndrome (ECS), a type of Cushing's syndrome caused by the body overproducing cortisol on its own.

Buy Zokinvy (lonafarnib) Online

From $31,401.66
(0 Reviews)
DISEASE INDICATIONS: Progeria MANUFACTURER: Eiger Biopharmaceuticals USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Zokinvy (lonafarnib) is a prescription medication used to treat Hutchinson-Gilford progeria syndrome (HGPS) and processing-deficient progeroid laminopathies (PDPL) in children aged 12 months and older. HGPS and PDPL are rare genetic disorders that cause premature aging.

Buy Oxlumo (lumasiran) Online

$64,110.43
(0 Reviews)
DISEASE INDICATIONS: Primary hyperoxaluria type 1 (PH1) MANUFACTURER: Alnylam Pharmaceuticals USAGE: Subcutaneous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Oxlumo (lumasiran) is a prescription medicine used to treat primary hyperoxaluria type 1 (PH1) in children and adults. PH1 is a rare genetic disorder that causes the body to produce too much of a substance called oxalate. Oxaluria can cause kidney stones, damage to the kidneys and other organs, and even death.

Buy Leqvio (inclisiran) Online

$2,671.00
(0 Reviews)
DISEASE INDICATIONS: Hypercholesterolemia MANUFACTURER: Novartis USAGE: Subcutaneous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Kerendia (finerenone) is a nonsteroidal mineralocorticoid receptor antagonist (MRA) approved by the US Food and Drug Administration (FDA) to reduce the risk of kidney failure, cardiovascular death, heart attack, and hospitalization for heart failure in adults with chronic kidney disease (CKD) associated with type 2 diabetes (T2D).

Buy Evkeeza (evinacumab) Online

(0 Reviews)
DISEASE INDICATIONS: Hypercholesterolemia MANUFACTURER: Regeneron Pharmaceuticals, Inc. USAGE: Intravenous MEDICINE APPROVED BY: Food and Drug Administration (FDA) Evkeeza (evinacumab) is a fully human monoclonal antibody that binds to and inhibits angiopoietin-like 3 (ANGPTL3), a protein that plays a key role in lipid metabolism. It is the first FDA-approved treatment that binds to and blocks the function of ANGPTL3.

Buy Kerendia (finerenone) Online

From $618.20
(0 Reviews)
Kerendia (finerenone) is a nonsteroidal mineralocorticoid receptor antagonist (MRA) approved by the US Food and Drug Administration (FDA) to reduce the risk of kidney failure, cardiovascular death, heart attack, and hospitalization for heart failure in adults with chronic kidney disease (CKD) associated with type 2 diabetes (T2D).

Back to Top
Product has been added to your cart